Drug intelligence / Profile preview

copper cu 64-dota b-fab

Development stage
Phase 1
Lead developer
Stanford University
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics, Recombinant Proteins and Enzymes, Antibody Fragments → Engineered Antibody Formats → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Copper Cu 64-DOTA B-Fab is a radiopharmaceutical agent composed of a humanized antibody fragment (B-Fab) conjugated to the chelator DOTA and labeled with the positron-emitting radioisotope copper-64. It is designed for use as a PET imaging tracer to evaluate expression of cancer antigen CA6 in tumors, particularly in patients with ovarian and breast cancer. The mechanism involves specific binding of the B-Fab fragment to CA6-expressing tumor cells, allowing for non-invasive visualization and localization using PET/CT imaging. This agent enables assessment of CA6 status in tumors, which may inform diagnosis or therapeutic planning[3].

Other names
64Cu-DOTA-B-Fabcopper-64 DOTA B-Fabcopper64 DOTA B-Fabcopper 64 DOTA B-Fab
02

Targets

CA6 (Carbonic Anhydrase 6)

Beyond the preview

Go deeper on copper cu 64-dota b-fab.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on copper cu 64-dota b-fab.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call